Conclusion
AF monitoring following ablation is an indispensable tool to guide
patient management. The traditional strategy of intermittent external
ambulatory monitoring devices to assess recurrence of AF as a binary
outcome is increasingly being recognized as inaccurate and misses the
opportunity for tailored patient management. AF burden and duration
assessment by personal monitoring devices, in the form of direct to
consumer smart watches and smart phones, holds promise to guide
individual patient management and is likely to empower patients to
manage their own disease.